The proteasome inhibitor PS-341 modulates VEGF secretion and activity in multiple myeloma.

被引：0
|
作者：
Mitsiades, N
Mitsiades, CS
Poulaki, V
Fanourakis, G
Chauhan, D
Munshi, NC
Hideshima, T
Anderson, KC
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3220
引用
收藏
页码：815A / 815A
页数：1
相关论文
共 50 条
  • [1] Development of the proteasome inhibitor PS-341
    Adams, J
    ONCOLOGIST, 2002, 7 (01): : 9 - 16
  • [2] PS-341 is active in multiple myeloma: Preliminary report of a phase I trial of the proteasome inhibitor PS-341 in patients with hematologic malignancies.
    Stinchcombe, TE
    Mitchell, BS
    Depcik-Smith, N
    Adams, J
    Elliott, P
    Shea, TC
    Orlowski, RZ
    BLOOD, 2000, 96 (11) : 516A - 516A
  • [3] Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP in a syngeneic, orthotopic model of multiple myeloma.
    Goel, A
    Dispenzieri, A
    Geyer, SM
    Greiner, S
    Russell, SJ
    BLOOD, 2005, 106 (11) : 964A - 964A
  • [4] The proteasome inhibitor PS-341 in cancer therapy
    Teicher, BA
    Ara, G
    Herbst, R
    Palombella, VJ
    Adams, J
    CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2638 - 2645
  • [5] Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
    Hideshima, T
    Mitsiades, C
    Akiyama, M
    Hayashi, T
    Chauhan, D
    Richardson, P
    Schlossman, R
    Podar, K
    Munshi, NC
    Mitsiades, N
    Anderson, KC
    BLOOD, 2003, 101 (04) : 1530 - 1534
  • [6] The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents
    Ma, MH
    Yang, HH
    Parker, K
    Manyak, S
    Friedman, JM
    Altamirano, C
    Wu, ZQ
    Borad, MJ
    Frantzen, M
    Roussos, E
    Neeser, J
    Mikail, A
    Adams, J
    Sjak-Shie, N
    Vescio, RA
    Berenson, JR
    CLINICAL CANCER RESEARCH, 2003, 9 (03) : 1136 - 1144
  • [7] Proteasome inhibitor PS-341 inhibits human multiple myeloma cell growth in a murine model.
    LeBlanc, R
    Catley, L
    Hideshima, T
    Pien, CS
    Elliott, PJ
    Anderson, KC
    BLOOD, 2001, 98 (11) : 774A - 774A
  • [8] PS-341, a proteasome inhibitor for cancer treatment.
    Adams, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U665 - U665
  • [9] Current clinical trials for the proteasome inhibitor PS-341
    不详
    ONCOLOGY-NEW YORK, 2000, 14 (11): : 1589 - +
  • [10] The proteasome inhibitor PS-341 is more cytotoxic in myeloma cells adhered to fibronectin.
    Landowski, TH
    Adams, J
    Dalton, WS
    BLOOD, 2002, 100 (11) : 393B - 393B
12345